We investigated the toxicity of bisphenol A (BPA) by determining the gene expression of nerve growth factor (Ngf) in the embryonic mouse cell line mHypoE-N44 derived from the hypothalamus exposed to BPA dose range between 0.02 and 200 µmol L -1 for 3 h. Ngf mRNA levels decreased in a dose-dependent manner, with significant reductions observed in the 2 to 50 µmol L -1 BPA treatment groups compared to controls. However, at 100 to 200 µmol L -1 the Ngf mRNA gradually increased and was significantly higher than control, while the expression of the apoptosis-related genes Caspase 3 and transformation-related protein 73 decreased significantly. These results suggest that in an embryonic hypothalamic cell line the higher doses of BPA induce a unique pattern of Ngf gene expression and that BPA has the potential to suppress apoptosis essential for early-stage brain development.
Bisphenol A (BPA) is one of the most abundantly produced chemicals worldwide that can disrupt endocrine function by mimicking the action of oestrogen. It has been detected in maternal serum, umbilical cord, foetal serum, and full-term amniotic fluid passing through the placenta (1, 2) and can also penetrate the blood-brain barrier (3) . Because foetuses are extremely sensitive to chemicals with hormonelike activity, and even small changes induced by oestrogen-mimicking chemicals can lead to changes in brain function and behaviour (4) , there is a growing concern that BPA exposure can disrupt foetal brain development/function or neuronal differentiation. Recent studies have demonstrated that BPA exposure can affect neurogenesis during gestation (5, 6) or in young adult mice (7) .
Neurotrophins are crucial to the survival, development/differentiation, and function of neurons. The neurotrophin family includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and NT-4/5 (8) . NGF and BDNF initiate signalling by binding to specific highaffinity receptors, namely neurotrophic tyrosine kinase receptor type 1 (NTRK1) and type 2 (NTRK2), respectively (9) . We previously showed that BPA decreased the Bdnf gene expression in embryonic hypothalamic cells and affected the BDNF-NTRK2 neurotrophin system (10). Seki et al. (11) have found that BPA causes morphological changes in NGFinduced differentiation and inhibits neurite extension in a PC12 cell line. It has also been reported to induce changes in both dendritic and synaptic development in foetal hypothalamic cells (12) . Because NGF regulates dendritic morphology and synaptic connectivity during development (13) , these findings suggest that BPA would affect NGF-related development in embryonic hypothalamic cells and that the NGF-NTRK1 neurotrophin system could be a target of BPA. However, little is known about the relationship between BPA and NGF in developing hypothalamic cells.
Another mechanism potentially affected by BPA and regulated by neurotrophins is apoptosis (programmed cell death). In neural development, apoptosis plays an essential role in optimising synaptic connections, removing unnecessary neurons, and forming neuronal patterns (14) . In embryonic neurons such apoptosis is regulated by neurotrophins (15, 16) . Therefore, we also wanted to see how the effects of BPA on the NGF-NTRK1 neurotrophin system affect apoptosis in developing hypothalamic cells.
MATERIALS AND METHODS
We focused our study on the previously unknown effects of BPA on the gene expression of Ngf, Ntrk1, Caspase 3 (Casp3), and the transformation-related protein 73 (Trp73), which is also involved in apoptosis (17) , in developing hypothalamic cells. We used the embryonic mouse hypothalamic cell line N-44 (mHypoE-N44) as the foetal hypothalamic cell model and assessed the effects of BPA on gene expression using real-time reverse transcription polymerase chain reaction (real-time RT-PCR).
Cell culture
The mHypoE-N44 cell line was purchased from CELLutions Biosystems, Inc. (Toronto, ON, Canada). This cell line is immortalised from mouse embryonic hypothalamic primary cultures (days 15, 17, and 18) by retroviral transfer of SV40 T-Ag. We used this cell line as a suitable model for foetal hypothalamus. The cells were plated at a density of 2x10 4 cells in 35-mm tissue culture dishes pre-coated with collagen type I (Corning, Inc., Corning, NY, USA) and were cultured in minimum essential medium alpha (MEMα; Invitrogen-Gibco, Carlsbad, CA, USA) supplemented with 10 % foetal bovine serum (FBS; Biowest, Nuaille, France). The cells were incubated at a permissive temperature (37 °C) in a humid atmosphere with 5 % CO 2 .
Incubation of the mHypoE-N44 cells with BPA
BPA (Junsei Chemical Co., Tokyo, Japan) in the concentration range of 0.02 to 200 µmol L -1 was dissolved in 0.1 % (final concentration) dimethyl sulphoxide (DMSO; Wako, Osaka, Japan). The choice of the upper range limit was based on an in vitro study by Kim et al. (18) showing no notable cytotoxicity of BPA in concentrations ≤200 µmol L -1
. We therefore assumed that treatment with ≤200 µmol L -1 BPA for 3 h would have no effect on cell viability. In addition, the 0.1 % DMSO vehicle was not toxic to the mHypoE-N44 cells and had no effect on cell viability or cell division. The cells were first cultured in phenolred-free MEMα supplemented with 0.5 % charcoalstripped FBS at 37 °C for 24 h. Then the medium was supplemented with BPA, and incubation continued for another 3 h. The cells treated with 0.1 % DMSO served as controls. All experiments were performed in triplicate.
Separation of total RNA and real-time RT-PCR
Total cellular RNA was extracted from the mHypoE-N44 cells using an RNeasy kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. DNase-treated RNA (1 μg) was reverse transcribed to cDNA using the Super Script III FirstStrand Synthesis System (Invitrogen Corp., Carlsbad, CA, USA). Gene expression was examined using quantitative RT-PCR. The cDNA was amplified through PCR with primer sets specific to mouse Ngf, Ntrk1, Casp3, Trp73, and oestrogen-related receptor γ (Errγ), which is a putative BPA receptor. Real-time PCR was performed using a LightCycler rapid thermal cycler system (Roche Diagnostics Ltd., Lewes, UK) with LightCycler FastStart DNA Master PLUS SYBR Green I mix (Roche Diagnostics Ltd.). Primer sequences for Ngf, Ntrk1, Trp73, and glyceraldehyde-3'-phosphate dehydrogenase (Gapdh) have been described previously (10, 19) . Casp3 primer sequences were 5'-CTG CCG GAG TCT GAC TGG AA-3' and 5'-ATC AGT CCC ACT GTC TGT CTC AAT G-3'. Errγ primer sequences were 5'-TCA AAG CCC TCA CCA CAC TCT-3' and 5'-GCC AGG GAC AGT GTG GAG AA-3'. Amplification of Gapdh mRNA was used as an internal positive control. The level of Gapdh mRNA was stable and similar between each sample, and the amounts of each mRNA were normalised to the Gapdh mRNA level in each sample.
Statistical analysis
Statistical analyses were performed using one-way analysis of variance (ANOVA) and Bonferroni-Dunn post-hoc tests with the StatView software (version 5.0; SAS Institute Inc., Cary, NC, USA). The data for each BPA-treated group were compared with those for the controls. P values of less than 0.05 were considered statistically significant. BPA compared to control. An in vitro study by Yokosuka et al. (12) has shown that BPA induces changes in both dendritic and synaptic development in foetal rat hypothalamic cells via alteration of microtubule-associated protein 2 (MAP2) and synapsin I expression, which serve as protein markers of neuronal growth and synaptogenesis, respectively (20) . In addition to MAP2 and synapsin I, we believe that hypothalamic cell dendritic and synaptic development is also affected by changes in Ngf expression, given the important role of NGF in both dendritic morphology and synaptic connectivity (13) . Further studies such as Western blotting should be conducted to evaluate the changes at the protein level.
RESULTS AND DISCUSSION
Unexpectedly however, the Ngf mRNA level significantly increased with exposure to ≥100 µmol L -1 BPA (P<0.01) compared to control. Lee et al. (21) reported that the effect of BPA on neuronal cells derived from the E18 rat cortex differed between low (below 50 µmol L -1 ) and high (higher than 100 µmol L -1 ) doses of BPA. In addition, the authors suggested that a concentration of 50 µmol L -1 BPA might be a cut-off dose for the induction of adverse effects in neuronal cells. In our study, the dramatic change in Ngf mRNA expression was observed between 50 and 100 µmol L 
The data have been normalised to the Gapdh mRNA level in each sample and are expressed as a value relative to this internal control. Each column represents the mean ± SD (standard deviation) (n=3 for each group). *P<0.01 (significantly different from control)
2). We have previously reported that treatment with 200 µmol L -1 BPA decreases Bdnf gene expression without affecting the BDNF receptor gene Ntrk2 (10) . Both our studies suggest that the adverse effects of higher BPA doses on the NGF/NTRK1 and BDNF/ NTRK2 systems occur through the alteration of gene expression of the ligands, not of their receptors. high levels of BPA adversely affect normal development of the foetal hypothalamus by allowing the survival of cells that are destined for apoptotic thinning necessary for normal formation of the CNS. Furthermore, because the effect of BPA on the Ngf gene expression significantly differed with doses, adverse effects resulting from the change in Ngf levels may also be dose-dependent. It is possible that the effects shift from altering dendritic and synaptic development to affecting naturally occurring essential cell death.
On the other hand, Casp3 and Trp73 mRNA expression did not drop significantly in the cells treated with lower doses of BPA (data not shown), but only in those treated with 200 µmol L -1 BPA (P<0.01 and P<0.05, respectively, compared to the controls) ( Figure 3 ). In the early developmental stage, apoptosis is an essential physiological process for the formation of a normal central nervous system (CNS), and Casp3 plays an important role in apoptosis during brain development (14) . TRP73 is also reported to induce apoptosis (22, 23) . Therefore, our results suggest that BPA has the potential to suppress normal apoptosis in embryonic hypothalamic cells and are in line with the findings of Negishi et al. (24) , who reported that BPA significantly inhibited Casp3 activity in foetal rat neurons treated with staurosporine, an inducer of apoptosis. Given that our highest dose of BPA decreased the expression of Casp3 and Trp73 and increased the expression of Ngf, which supports the survival and maintenance of neurons in the brain during embryonic development (25), we assume that Matsushima et al. (26) have reported that BPA binds strongly to ERRγ, a receptor highly expressed in the placenta (27) , which suggests that BPA has a high potential for accumulating in the placental tissue. In our study, Errγ mRNA expression gradually started to decrease from 100 µmol L -1 BPA only to reach significant reduction at 200 µmol L -1 ( Figure 4 ). Although it is unclear how much a dose of BPA can affect the embryonic hypothalamus through the placenta, higher doses may downregulate Errγ gene expression in foetal hypothalamic cells.
In summary, our findings suggest that in an embryonic hypothalamic cell line BPA has the potential to suppress apoptosis by lowering Casp3 and Trp73 mRNA levels and that higher doses of BPA may modulate NGF-mediated neuronal development by altering Ngf gene expression, but the effect is strongly dose-dependent. Further investigation is needed to determine the significance of these results at the level of organism. , razine Ngf mRNA značajno su se povećale u odnosu na kontrolu, a ekspresija gena kaspaze 3 i transformacijskog proteina 73 značajno snizila. Ti rezultati upućuju na to da visoke doze BPA u embrionskoj hipotalamičkoj staničnoj liniji stvaraju jedinstveni obrazac ekspresije gena Ngf te da BPA može suprimirati apoptozu koja je nužna za rani razvoj mozga.
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